동물용 정형외과 임플란트 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Veterinary Orthopedic Implants Market was valued at USD 617 million in 2024 and is projected to expand at a CAGR of 7.7% from 2025 to 2034. The rising prevalence of orthopedic disorders and musculoskeletal injuries in animals is a key factor driving market growth. As more pets and livestock develop mobility-related issues, the demand for advanced surgical solutions continues to surge. Veterinary professionals are increasingly adopting orthopedic implants to improve treatment outcomes, while technological advancements in implant materials and design are enhancing surgical precision.

Pet owners are becoming more proactive about their animal's health, fueling demand for specialized orthopedic procedures. The growing awareness of treatment options, in line with improved diagnostic capabilities, is leading to higher adoption rates for veterinary implants. The increasing number of veterinarians trained in orthopedic procedures and the expansion of veterinary clinics with advanced surgical capabilities are further accelerating market expansion. Additionally, the rise in pet insurance policies covering orthopedic procedures is encouraging pet owners to opt for surgeries, further propelling the adoption of veterinary orthopedic implants.

The implants segment dominated the market, generating USD 401 million in 2024, primarily due to the growing need for surgical interventions in animals with orthopedic injuries. Veterinary professionals are relying more on plates, bone screws, joint implants, and other surgical devices to treat fractures, ligament tears, and joint disorders. The rising number of procedures addressing these conditions is pushing demand for advanced implant designs that offer greater precision, reduce recovery time, and enhance mobility in treated animals. Minimally invasive surgical techniques are gaining traction as they provide more efficient solutions for treating musculoskeletal conditions with reduced post-operative complications.

Companion animals accounted for a dominant 72.5% share of the veterinary orthopedic implants market in 2024, driven by a significant surge in pet adoption. With more households worldwide owning pets, particularly dogs and cats, spending on veterinary care has increased. Pet owners are investing more in orthopedic treatments to improve their pets' quality of life, leading to higher demand for specialized implants. The trend of humanizing pets-where owners view animals as family members-is further contributing to market expansion.

North America led the global market, holding a 45.2% share in 2024, supported by high pet ownership rates and an advanced veterinary healthcare infrastructure. The region's strong presence of specialized veterinary clinics and hospitals equipped with state-of-the-art surgical technologies has boosted demand for orthopedic implants. Ongoing research and development efforts in veterinary orthopedics are driving innovation, making procedures more effective and accessible. With continued advancements in implant technology and increasing pet care expenditure, North America remains a dominant force in the veterinary orthopedic implants market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of orthopedic conditions in dogs
    • 3.2.1.2 Advancements in veterinary orthopedic technology
    • 3.2.1.3 Expansion of pet insurance coverage
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of orthopedic procedures and implants
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Implants
  • 5.2.1 Plates
    • 5.2.1.1 TPLO plates
    • 5.2.1.2 TTA plates
    • 5.2.1.3 Specialty plates
    • 5.2.1.4 Trauma plates
    • 5.2.1.5 Other plates
  • 5.2.2 Joint implants
  • 5.2.3 Bone screws and anchors
  • 5.2.4 Pins and wires
  • 5.2.5 Other implants
• 5.3 Instruments

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Companion animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Other companion animals
• 6.3 Livestock animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Tibial Plateau Leveling Osteotomy (TPLO)
• 7.3 Tibial Tuberosity Advancement (TTA)
• 7.4 Joint replacement
  • 7.4.1 Hip replacement
  • 7.4.2 Knee replacement
  • 7.4.3 Elbow replacement
  • 7.4.4 Ankle replacement
• 7.5 Trauma
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals and clinics
• 8.3 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 AmerisourceBergen Corporation
• 10.2 Arthrex Vet Systems
• 10.3 B. Braun SE
• 10.4 BlueSAO
• 10.5 BioMedtrix
• 10.6 DePuy Synthes (Johnson & Johnson)
• 10.7 Fusion Implants
• 10.8 Integra LifeSciences
• 10.9 Kyon
• 10.10 Movora (Vimian Group AB)
• 10.11 Narang Medical Limited
• 10.12 Orthomed
• 10.13 Ortho Max
• 10.14 Veterinary Instrumentation
• 10.15 STERIS